Updated Jul 16, 2026
Vultaggio Vincent is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $111K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-11 | ZNTL | Zentalis Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 6.9K | $2.42 | $17K |
| 2026-02-11 | ZNTL | Zentalis Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 3.4K | $2.39 | $8K |
| 2026-02-11 | ZNTL | Zentalis Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 30.0K | $2.43 | $73K |
| 2026-02-05 | ZNTL | Zentalis Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 556 | $2.52 | $1K |
| 2026-02-05 | ZNTL | Zentalis Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 2.5K | $2.55 | $6K |
| 2024-10-04 | ZNTL | Zentalis Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 1.6K | $3.18 | $5K |
Vultaggio Vincent is a corporate insider — currently tracked as PAO and PFO. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($111K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Vultaggio Vincent profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.